Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol.

Date publication

juillet 2024

Journal

The Cochrane database of systematic reviews

Auteurs

Membres identifiés du Cancéropôle Est :
Pr WESTEEL Virginie

Tous les auteurs :
Marchal C, Orillard E, Calais F, Westeel V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38958139

Résumé

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (ICI) as monotherapy or in combination compared to standard of care for elderly people (≥ 65 years) with non-small cell lung cancer (NSCLC).

Mots clés

Humans, Carcinoma, Non-Small-Cell Lung, therapy, Lung Neoplasms, therapy, Aged, Immune Checkpoint Inhibitors, therapeutic use, Immunotherapy, methods, Systematic Reviews as Topic, Randomized Controlled Trials as Topic, Standard of Care

Référence

Cochrane Database Syst Rev. 2024 07 3;7(7):CD014907